Cognitive-behavioral therapy helps prevent relapse and recurrence of panic disorder following Alprazolam discontinuation: A long-term follow-up of the Peoria and Dartmouth studies

Journal of Consulting and Clinical Psychology

Volumn 67, Issue 1, 1999, Pages 151-156

  Bruce, Timothy J ^a   Spiegel, David A ^c   Hegel, Mark T ^b  

^a UNIVERSITY OF ILLINOIS   (United States)

^b DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^c Dartmouth Hitchcock Medical Center ^*

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM;

ARTICLE; BEHAVIOR THERAPY; CLINICAL ARTICLE; COGNITIVE THERAPY; HUMAN; PANIC; RECURRENT DISEASE; TREATMENT OUTCOME;

ALPRAZOLAM; BENZODIAZEPINES; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PANIC DISORDER; RECURRENCE; SUBSTANCE WITHDRAWAL SYNDROME; SURVIVAL ANALYSIS;

EID: 0033056978     PISSN: 0022006X     EISSN: None     Source Type: Journal    
DOI: 10.1037/0022-006X.67.1.151     Document Type: Article

References (26)

1. American Psychiatric Association. (1987). Diagnostic and statistical manual of mental disorders (3rd ed., rev.). Washington, DC: Author.
2. Barlow, D. H. (1988). Anxiety and its disorders: The nature and treatment of anxiety and panic. New York: Guilford Press.
3. Barlow, D. H., & Craske, M. G. (1989). Mastery of your anxiety and panic. Albany, NY: Graywind.
4. Beck, A. T., Ward, C. H., Mendelson, M., Mock, J., & Erbaugh, J. (1961). An inventory for measuring depression. Archives of General Psychiatry, 41, 561-571.
5. Brown, T. A., & Barlow, D. H. (1995). Long-term outcome in cognitive-behavioral treatment of panic disorder: Clinical predictors and alternative strategies for assessment. Journal of Consulting and Clinical Psychology, 63, 754-765.
6. Bruce, T. J., Spiegel, D. A., Gregg, S. F., & Nuzzarello, A. (1995). Predictors of alprazolam discontinuation with and without cognitive behavior therapy in panic disorder. American Journal of Psychiatry, 152, 1156-1160.
7. Chambless, D. L., Caputo, G. C., Bright, P., & Gallagher, R. (1984). Assessment of fear in agoraphobics: The Body Sensations Questionnaire and the Agoraphobic Cognitions Questionnaire. Journal of Consulting and Clinical Psychology, 52, 1090-1097.
8. Chambless, D. L., Caputo, G. C., Jasin, S. E., Gracely, E. J., & Williams, C. (1985). The Mobility Inventory for Agoraphobia. Behaviour Research and Therapy, 23, 35-44.
9. Clark, D. M. (1986). A cognitive approach to panic. Behaviour Research and Therapy, 24, 461-470.
10. Craske, M. G., & Barlow, D. H. (1990). Leaders guide for mastery of your anxiety and panic. Albany, NY: Graywind.
11. Fava, G., Zielezny, M., Savron, G., & Grandi, S. (1995) Long-term effects of behavioural treatment for panic disorder with agoraphobia. British Journal of Psychiatry, 166, 87-92.
12. Hegel, M. T., Ravaris, C. I., & Ahles, T. A. (1994). Combined cognitive-behavioral and time-limited alprazolam treatment of panic disorder. Behavior Therapy, 25, 183-195.
13. Hosmer, D. W., & Lemeshow, S. (1989). Applied logistic regression. New York: Wiley.
14. Kendall, P. K., & Grove, W. M. (1988). Normative comparisons in therapy outcome. Behavioral Assessment, 10, 147-158.
15. Marks, I. M., Swinson, R. P., Basoglu, M., Kuch, K., Noshirvani, H., O'Sullivan, G., Lelliott, P. T., Kirby, M., McNammee, G., Sengun, S., & Wickwire, K. (1993). Alprazolam and exposure alone and combined in panic disorder with agoraphobia: A controlled study in London and Toronto. British Journal of Psychiatry, 162, 776-787.
16. Noyes, R., Garvey, M. J., Cook, B., & Suelzer, M. (1991). Controlled discontinuation of benzodiazepine treatment for patients with panic disorder. American Journal of Psychiatry, 148, 517-523.
17. Otto, M. W., Pollack, M. H., Sachs, G. S., Reiter, S. R., Meltzer-Brody, S., & Rosenbaum, J. F. (1993). Discontinuation of benzodiazepine treatment: Efficacy of cognitive-behavioral therapy for patients with panic disorder. American Journal of Psychiatry, 150, 1485-1490.
18. Pecknold, J. C., Swinson, R. P., Kuch, K., & Lewis, C. P. (1988). Alprazolam in panic disorder and agoraphobia, results from a multicenter trial: III. Discontinuation effects. Archives of General Psychiatry, 45, 429-438.
19. Reiss, S., Peterson, R., Gursky, D. M., & McNally, R. J. (1986). Anxiety sensitivity, anxiety frequency, and the prediction of fearfulness. Behaviour Research and Therapy, 24, 1-8.
20. Sanderson, W. C., & Wetzler, S. (1993). Observations on the cognitive behavioral treatment of panic disorder: Impact of benzodiazepines. Psychotherapy, 30, 125-132.
21. Schweizer, E., Rickels, K., Case, W. G., & Greenblatt, D. J. (1990). Long-term therapeutic use of benzodiazepines: II. Effects of gradual taper. Archives of General Psychiatry, 47, 908-915.
22. Sheehan, D. V. (1982). Sheehan Panic and Anticipatory Anxiety Scale. In P. A. Keller & L. G. Ritt (Eds.), Innovations in clinical practice: A sourcebook (Vol. 6, pp. 34-37). Sarasota, FL: Professional Resource Exchange.
23. Sheehan, D. V. (1983). The anxiety disease. New York: Bantam Books.
24. Spiegel, D. A., & Bruce, T. J. (1997). Benzodiazepines and exposure-based cognitive behavior therapies for panic disorder: Conclusions from combined treatment trials. American Journal of Psychiatry, 154, 773-781.
25. Spiegel, D. A., Bruce, T. J., Gregg, S. F., & Nuzzarello, A. (1994). Does cognitive behavior therapy assist slow-taper alprazolam discontinuation in panic disorder? American Journal of Psychiatry, 151, 876-881.
26. Williams, S. L., & Falbo, J. (1996). Cognitive and performance-based treatments for panic attacks in people with varying degrees of agoraphobic disability. Behaviour Research and Therapy, 34, 253-264.